These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7863829)

  • 1. Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage.
    Bikle DD; Morey-Holton ER; Doty SB; Currier PA; Tanner SJ; Halloran BP
    J Bone Miner Res; 1994 Nov; 9(11):1777-87. PubMed ID: 7863829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal unloading induces selective resistance to the anabolic actions of growth hormone on bone.
    Halloran BP; Bikle DD; Harris J; Autry CP; Currier PA; Tanner S; Patterson-Buckendahl P; Morey-Holton E
    J Bone Miner Res; 1995 Aug; 10(8):1168-76. PubMed ID: 8585419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy.
    Murakami H; Nakamura T; Tsurukami H; Abe M; Barbier A; Suzuki K
    J Bone Miner Res; 1994 Sep; 9(9):1355-64. PubMed ID: 7529459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading.
    Halloran BP; Bikle DD; Harris J; Tanner S; Curren T; Morey-Holton E
    J Bone Miner Res; 1997 Jul; 12(7):1068-74. PubMed ID: 9200006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
    Firling CE; Evans GL; Wakley GK; Sibonga J; Turner RT
    J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats.
    Seedor JG; Quartuccio HA; Thompson DD
    J Bone Miner Res; 1991 Apr; 6(4):339-46. PubMed ID: 1858520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal unloading induces resistance to insulin-like growth factor I.
    Bikle DD; Harris J; Halloran BP; Morey-Holton ER
    J Bone Miner Res; 1994 Nov; 9(11):1789-96. PubMed ID: 7532347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate effects in rat unloaded hindlimb bone loss model: three-dimensional microcomputed tomographic, histomorphometric, and densitometric analyses.
    Barou O; Lafage-Proust MH; Martel C; Thomas T; Tirode F; Laroche N; Barbier A; Alexandre C; Vico L
    J Pharmacol Exp Ther; 1999 Oct; 291(1):321-8. PubMed ID: 10490920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
    Cui L; Wu T; Liu YY; Deng YF; Ai CM; Chen HQ
    Acta Pharmacol Sin; 2004 May; 25(5):678-84. PubMed ID: 15132837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
    Marie PJ; Hott M; Modrowski D; De Pollak C; Guillemain J; Deloffre P; Tsouderos Y
    J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex vivo cultures.
    Grano M; Mori G; Minielli V; Barou O; Colucci S; Giannelli G; Alexandre C; Zallone AZ; Vico L
    Calcif Tissue Int; 2002 Mar; 70(3):176-85. PubMed ID: 11907715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
    Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N
    J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effect of treadmill exercise and 17 beta-estradiol replacement on prevention of tibial bone loss in adult ovariectomized rat.
    Yeh JK; Liu CC; Aloia JF
    J Bone Miner Res; 1993 Jun; 8(6):677-83. PubMed ID: 8328309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The temporal response of bone to unloading.
    Globus RK; Bikle DD; Morey-Holton E
    Endocrinology; 1986 Feb; 118(2):733-42. PubMed ID: 3943489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of reloading on bone volume, osteoblast number, and osteoprogenitor characteristics: studies in hind limb unloaded rats.
    Basso N; Jia Y; Bellows CG; Heersche JN
    Bone; 2005 Sep; 37(3):370-8. PubMed ID: 16005699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.
    Miller SC; Jee WS
    Anat Rec; 1979 Mar; 193(3):439-62. PubMed ID: 154858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
    Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
    J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
    Sato M; Grasser W; Endo N; Akins R; Simmons H; Thompson DD; Golub E; Rodan GA
    J Clin Invest; 1991 Dec; 88(6):2095-105. PubMed ID: 1661297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats.
    Azuma Y; Oue Y; Kanatani H; Ohta T; Kiyoki M; Komoriya K
    J Pharmacol Exp Ther; 1998 Jul; 286(1):128-35. PubMed ID: 9655851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.